2019冠状病毒病(COVID-19)大流行期间未被发现的胎儿生长受限
这项回顾性队列研究比较了COVID-19大流行前(2019年4月至6月)与大流行期间(2020年4月至7月)分娩小于胎龄儿(SGA)新生儿的患者中未产前诊断胎儿生长受限(FGR)的比例,共268例符合纳入标准。大流行期间分娩SGA新生儿的患者未检出FGR的比例显著高于大流行前(70.1% vs 58.1%,P=.04),且远程医疗访视更多而面对面产前检查、宫高测量记录和生长超声更少。作者认为这些数据可能进一步支持自我评估宫高或常规晚孕期生长超声以识别胎儿生长异常。
要点
- 大流行期间分娩SGA新生儿的患者未检出FGR的比例为70.1%,高于大流行前的58.1%(P=.04)。
- 大流行期间患者远程医疗访视更多,面对面产前检查、宫高测量记录和生长超声更少。
- 作者认为数据可能支持自我评估宫高或常规晚孕期生长超声来识别胎儿生长异常。
核心结论
- 大流行期间分娩SGA新生儿的患者未检出FGR的比例显著高于大流行前(70.1% vs 58.1%,P=.04)。
- 随着远程医疗持续被纳入产前保健,这些数据可能进一步支持自我评估宫高或常规晚孕期生长超声来识别胎儿生长异常。
研究设计与样本
- 回顾性队列研究,纳入2019年4月至6月(COVID-19大流行前)和2020年4月至7月(COVID-19大流行期间)分娩单胎SGA新生儿的患者,共268例符合纳入标准。
- 主要结局为两个时期未产前诊断的胎儿生长受限(FGR)的发生率。
主要发现
- 大流行期间分娩SGA新生儿的患者未检出FGR的比例为70.1%,大流行前为58.1%(P=.04)。
- 大流行期间分娩SGA新生儿的患者远程医疗访视更多,但面对面产前检查、宫高测量记录和生长超声更少。
临床怎么用
- 作者认为这些数据可能进一步支持自我评估宫高或常规晚孕期生长超声来识别胎儿生长异常。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This was a retrospective cohort study of patients who delivered singleton, small-for-gestational-age (SGA) neonates between April and June 2019, before the coronavirus disease 2019 (COVID-19) pandemic (pre-COVID-19), and between April and July 2020, during the pandemic (COVID-19 epoch). The primary outcome was the rate of undetected antenatal fetal growth restriction (FGR) in the two periods. A total of 268 patients met inclusion criteria. Patients who delivered small-for-gestational-age neonates during the COVID-19 epoch were significantly more likely to have undetected FGR compared with those who delivered pre-COVID-19 (70.1% vs 58.1%, P =.04). Patients who delivered SGA neonates during the COVID-19 epoch had more telehealth visits but fewer in-person prenatal visits, recorded fundal height measurements, and growth ultrasonograms. As telemedicine continues to be incorporated into prenatal care, these data may lend further support toward self-assessment of fundal height or routine third-trimester growth ultrasonograms to identify fetal growth abnormalities.
引用
- Zafman KB, Cudjoe E, Levine LD, et al. Undetected Fetal Growth Restriction During the Coronavirus Disease 2019 (COVID-19) Pandemic. Obstet Gynecol. 2023. PMID: 36649315. doi:10.1097/AOG.0000000000005052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。